agilon health, inc. (AGL) stock
Close on Nov 12, 2026Market cap $1.85BP/E –Yield –
agilon health, inc. grew revenue 2.0% to $6.00B over the twelve months to Sep 30, 2026. Free cash flow was -$17.01M. At the latest close the market valued the company at $1.85B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.85B
- P/E ratio
- –
- Price to sales
- 0.31
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -0.92%
Fundamentals
- Revenue
- $6.00B
- Net income
- -$87.10M
- EPS, diluted
- -$5.44
- Free cash flow
- -$17.01M
- Diluted shares
- 18M
Trading
- Next earnings
- Feb 24, 2027 (estimated, during market hours)
- Previous close
- $114.81
- Open
- $113.79
- Day's range
- $109.67 – $115.00
- Volume
- 161,580
- Average volume (20 days)
- 219,596
- Index membership
- Russell 2000 (since Sep 2024), Russell 3000 (since May 2026)
- Beta (5 years)
- 1.27
- 52-week range
- $7.48 – $133.04
- RSI (14 days)
- 68.0
- Volatility (1 year)
- 166.7%
- Relative volume
- 0.60×
- WACC
- 11.3%
On 1 of our idea list: Institutions accumulating
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | AGL | S&P 500 | Difference | AGL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +29.0% | -2.7% | +31.7 pts | ||
| 3 months | +27.9% | -1.7% | +29.6 pts | ||
| Year to date | +540.6% | +11.9% | +528.7 pts | ||
| 1 year | +602.8% | +12.0% | +590.8 pts | ||
| 3 years | -61.0% | +78.2% | −139.2 pts | -27.0% | +21.2% |
| 5 years | -82.7% | +73.2% | −155.9 pts | -29.6% | +11.6% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases agilon health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- News
- Results
About agilon health
Services-Misc Health & Allied Services, NEC
agilon health operates a healthcare platform that collaborates with community-based primary care physicians to establish globally capitated, Medicare-centric care models. Through long-term partnership agreements, the company provides infrastructure, operational processes, capital, and technology—including its CORE system, HCC Manager software, and Minerva clinical data platform—to enable independent physician practices to transition to value-based care. Under this Total Care Model, the organization forms risk-bearing entities that contract with health plan payors to manage the comprehensive healthcare needs and associated medical expenses of attributed Medicare patients.
Company profile, executives and historyagilon health stock: common questions
What is agilon health's stock price?
AGL closed at $110.30 on Nov 12, 2026, down 3.93% on the day. Over the past 52 weeks it traded between $7.48 and $133.04.
What is agilon health's market cap?
agilon health was worth $1.85B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is AGL's P/E ratio?
agilon health lost money over the twelve months to Sep 30, 2026 (diluted EPS -$5.44), so it has no meaningful P/E ratio.
How much revenue does agilon health make?
agilon health reported revenue of $6.00B for the twelve months to Sep 30, 2026, up 2.0% from a year earlier.
Does agilon health pay a dividend?
No. agilon health has not paid a cash dividend over the last twelve months.
When does agilon health report earnings next?
agilon health is expected to report Q4 FY2026 results on Feb 24, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has AGL stock performed over the past year?
Including dividends, AGL returned +602.8% over the past year, against +12.0% for the S&P 500.
How many AGL shares are sold short?
1M shares were sold short at the latest FINRA report, 5.61% of the float, or 4.7 days of average trading volume.
Who are agilon health's competitors?
Companies most similar to agilon health by business, industry and size include DVA, PRVA, PGNY, CON, PIII.
See a number that looks wrong?